Literature DB >> 6651910

LDL-induced cytotoxicity and its inhibition by anti-oxidant treatment in cultured human endothelial cells and fibroblasts.

S A Evensen, K S Galdal, E Nilsen.   

Abstract

Low density lipoproteins (LDL) isolated by ultracentrifugation induce cytotoxic changes in cultured human endothelial cells (EC) and fibroblasts if the ratio between LDL cholesterol and the final protein concentration of the culture medium exceeds 0.10-0.12 mmol/g protein. In order to investigate if reactive oxygen species could contribute to the cytotoxicity, LDL were prepared in the presence of the antioxidants butylated hydroxytoluene (BHT) or superoxide dismutase (SOD), while routinely prepared LDL from the same donors served as control (N-LDL). A radiochromium release assay was used to evaluate cellular injury. BHT treatment of the LDL fraction virtually abolished LDL-induced cytotoxicity in cultured human EC and fibroblasts. SOD-LDL offered partial protection against LDL cytotoxicity. A positive correlation between the cytotoxicity of the various fractions and their content of malondialdehyde (MDA) further supports our conclusion that lipid peroxides in the LDL fractions mediate the cytotoxic effect on cultured cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6651910     DOI: 10.1016/0021-9150(83)90004-7

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  17 in total

1.  Effect of propionyl-L-carnitine on human endothelial cells.

Authors:  V W van Hinsbergh; M A Scheffer
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

2.  Inflammatory stress increases unmodified LDL uptake via LDL receptor: an alternative pathway for macrophage foam-cell formation.

Authors:  Qiang Ye; Yaxi Chen; Han Lei; Qing Liu; John F Moorhead; Zac Varghese; Xiong Z Ruan
Journal:  Inflamm Res       Date:  2009-06-17       Impact factor: 4.575

3.  Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis.

Authors:  M T Quinn; S Parthasarathy; L G Fong; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

4.  Effects of LDL and HDL on morphology of and prostacyclin synthesis in cultured vascular endothelial cells.

Authors:  S M Wei; W H Ren; Z Y Wang
Journal:  J Tongji Med Univ       Date:  1987

Review 5.  Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders.

Authors:  Satish K Srivastava; Umesh C S Yadav; Aramati B M Reddy; Ashish Saxena; Ravinder Tammali; Mohammad Shoeb; Naseem H Ansari; Aruni Bhatnagar; Mark J Petrash; Sanjay Srivastava; Kota V Ramana
Journal:  Chem Biol Interact       Date:  2011-02-24       Impact factor: 5.192

6.  The potential contribution of endothelin-1 to neurovascular abnormalities in streptozotocin-diabetic rats.

Authors:  N E Cameron; K C Dines; M A Cotter
Journal:  Diabetologia       Date:  1994-12       Impact factor: 10.122

7.  Endothelial cell-derived chemotactic activity for mouse peritoneal macrophages and the effects of modified forms of low density lipoprotein.

Authors:  M T Quinn; S Parthasarathy; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

8.  Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids.

Authors:  U P Steinbrecher; S Parthasarathy; D S Leake; J L Witztum; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

9.  Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats.

Authors:  N E Cameron; M A Cotter; V Archibald; K C Dines; E K Maxfield
Journal:  Diabetologia       Date:  1994-05       Impact factor: 10.122

10.  Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats.

Authors:  N E Cameron; M A Cotter; E K Maxfield
Journal:  Diabetologia       Date:  1993-04       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.